Cargando…

Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery

Multifunctional mesoporous silica nanoparticles (MSNs) are good candidates for multimodal applications in drug delivery, bioimaging, and cell targeting. In particular, controlled release of drugs from MSN pores constitutes one of the superior features of MSNs. In this study, a novel drug delivery ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tatsuya, Sugihara, Fuminori, Matsushita, Hisashi, Yoshioka, Yoshichika, Mizukami, Shin, Kikuchi, Kazuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496002/
https://www.ncbi.nlm.nih.gov/pubmed/28706648
http://dx.doi.org/10.1039/c4sc03549f
_version_ 1783247883986796544
author Nakamura, Tatsuya
Sugihara, Fuminori
Matsushita, Hisashi
Yoshioka, Yoshichika
Mizukami, Shin
Kikuchi, Kazuya
author_facet Nakamura, Tatsuya
Sugihara, Fuminori
Matsushita, Hisashi
Yoshioka, Yoshichika
Mizukami, Shin
Kikuchi, Kazuya
author_sort Nakamura, Tatsuya
collection PubMed
description Multifunctional mesoporous silica nanoparticles (MSNs) are good candidates for multimodal applications in drug delivery, bioimaging, and cell targeting. In particular, controlled release of drugs from MSN pores constitutes one of the superior features of MSNs. In this study, a novel drug delivery carrier based on MSNs, which encapsulated highly sensitive (19)F magnetic resonance imaging (MRI) contrast agents inside MSNs, was developed. The nanoparticles were labeled with fluorescent dyes and functionalized with small molecule-based ligands for active targeting. This drug delivery system facilitated the monitoring of the biodistribution of the drug carrier by dual modal imaging (NIR/(19)F MRI). Furthermore, we demonstrated targeted drug delivery and cellular imaging by the conjugation of nanoparticles with folic acid. An anticancer drug (doxorubicin, DOX) was loaded in the pores of folate-functionalized MSNs for intracellular drug delivery. The release rates of DOX from the nanoparticles increased under acidic conditions, and were favorable for controlled drug release to cancer cells. Our results suggested that MSNs may serve as promising (19)F MRI-traceable drug carriers for application in cancer therapy and bio-imaging.
format Online
Article
Text
id pubmed-5496002
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-54960022017-07-13 Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery Nakamura, Tatsuya Sugihara, Fuminori Matsushita, Hisashi Yoshioka, Yoshichika Mizukami, Shin Kikuchi, Kazuya Chem Sci Chemistry Multifunctional mesoporous silica nanoparticles (MSNs) are good candidates for multimodal applications in drug delivery, bioimaging, and cell targeting. In particular, controlled release of drugs from MSN pores constitutes one of the superior features of MSNs. In this study, a novel drug delivery carrier based on MSNs, which encapsulated highly sensitive (19)F magnetic resonance imaging (MRI) contrast agents inside MSNs, was developed. The nanoparticles were labeled with fluorescent dyes and functionalized with small molecule-based ligands for active targeting. This drug delivery system facilitated the monitoring of the biodistribution of the drug carrier by dual modal imaging (NIR/(19)F MRI). Furthermore, we demonstrated targeted drug delivery and cellular imaging by the conjugation of nanoparticles with folic acid. An anticancer drug (doxorubicin, DOX) was loaded in the pores of folate-functionalized MSNs for intracellular drug delivery. The release rates of DOX from the nanoparticles increased under acidic conditions, and were favorable for controlled drug release to cancer cells. Our results suggested that MSNs may serve as promising (19)F MRI-traceable drug carriers for application in cancer therapy and bio-imaging. Royal Society of Chemistry 2015-03-01 2014-12-23 /pmc/articles/PMC5496002/ /pubmed/28706648 http://dx.doi.org/10.1039/c4sc03549f Text en This journal is © The Royal Society of Chemistry 2014 http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Chemistry
Nakamura, Tatsuya
Sugihara, Fuminori
Matsushita, Hisashi
Yoshioka, Yoshichika
Mizukami, Shin
Kikuchi, Kazuya
Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title_full Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title_fullStr Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title_full_unstemmed Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title_short Mesoporous silica nanoparticles for (19)F magnetic resonance imaging, fluorescence imaging, and drug delivery
title_sort mesoporous silica nanoparticles for (19)f magnetic resonance imaging, fluorescence imaging, and drug delivery
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496002/
https://www.ncbi.nlm.nih.gov/pubmed/28706648
http://dx.doi.org/10.1039/c4sc03549f
work_keys_str_mv AT nakamuratatsuya mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery
AT sugiharafuminori mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery
AT matsushitahisashi mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery
AT yoshiokayoshichika mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery
AT mizukamishin mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery
AT kikuchikazuya mesoporoussilicananoparticlesfor19fmagneticresonanceimagingfluorescenceimaginganddrugdelivery